• Explore /
  • Poster
  • / Quality of life in patients with advanced high-grade ovarian cancer (HGOC) receiving maintenance therapies after first-line (1L) chemotherapy in the randomized phase III PAOLA-1/ENGOT-ov25 trial (NCT02477644).

Quality of life in patients with advanced high-grade ovarian cancer (HGOC) receiving maintenance therapies after first-line (1L) chemotherapy in the randomized phase III PAOLA-1/ENGOT-ov25 trial (NCT02477644).

Abstract Video & Slides Poster

Authors

null

Jean Emmanuel Kurtz

ICANS (Institut de Cancérologie Strasbourg Europe), Strasbourg, France

Jean Emmanuel Kurtz , Amélie Anota , Claire Cropet , Frank Priou , Philipp Harter , Sandro Pignata , Isabel Palacio , Edgar Petru , Hiroaki Kobayashi , Peter Vuylsteke , Gabriella Parma , Johanna Mäenpää , Eric Raymond , Paul Buderath , Domenica Lorusso , Ana Herrero , Nadia Raban , Florence Joly , Isabelle Laure Ray-Coquard , Eric Pujade-Lauraine

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Ovarian Cancer

Clinical Trial Registration Number

NCT02477644

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 5560)

DOI

10.1200/JCO.2022.40.16_suppl.5560

Abstract #

5560

Poster Bd #

439

Abstract Disclosures

Similar Posters

First Author: Florian Heitz

First Author: Jinan Liu

First Author: Patricia Pautier

First Author: Domenica Lorusso